Ebola Outbreak Pushing Development of Vaccines for Bundibugyo Strain
The current outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) and Uganda which began only a couple of weeks ago is already reportedly the third largest in history and, according to the World Health Organization’s (WHO) Director-General Tedros Adhanom Ghebreyesus, “spreading rapidly,” with more than 900 suspected cases of the […]
Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects
AstraZeneca plc, the largest and most profitable pharmaceutical company in the United Kindgdom1 has admitted in court documents that its COVID-19 vaccine, Vaxzevria, which was developed in partnership with the University of Oxford, can cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) in “very rare cases.” TTS is an immune disorder specifically associated with […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
FDA Grants EUA for Novavax’s COVID Vaccine
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]
FDA Approves Fourth COVID Shot. Fifth Shot Considered.
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]